A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: seizure (91), fit (337), spasm (42), tremor (21)

Blinatumomab

Description
Chemotherapy Protocol Acute lymphoblastic leukaemia (ALL) Blinatumomab (3, 4 day) Regimen • ALL – Blinatumomab (3, 4 day schedule) Indication • Treatment of Philadelphia-chrom
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Blinatumomab.pdf

Chlordiazepoxide - patient information

Description
This factsheet contains information about taking a medicine called chlordiazepoxide.
Url
/Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Chlordiazepoxide-1340-PIL.pdf

Pre-eclampsia - patient information

Description
This factsheet explains what pre-eclampsia is, what causes it, and the steps you and your maternity team can take to
Url
/Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Pre-eclampsia-4046-PIL.pdf

SMILE

Description
Chemotherapy Protocol LYMPHOMA PEGAPARGASE-DEXAMETHASONE-ETOPOSIDE-IFOSFAMIDE-METHOTREXATE (SMILE) Inpatient Regimen Regimen Lymphoma – InP-SMILE-Pegasparagase-Dexamethasone-Etoposide-IfosfamideMethotrexate Indication • Newly
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/SMILE-Ver1.pdf

ACCORD-2 master protocol

Description
CONFIDENTIAL ACCORD-2-001 – Master Protocol TITLE PAGE Protocol Title: ACCORD-2: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study
Url
/Media/Southampton-Clinical-Research/COVID-19/ACCORD/ACCORD-2-master-protocol.pdf

BEACON protocol v8.0 07Mar2023 signed

Description
A randomised phase IIb trial of BE AC v izumab added to Temozolomide O ± Irin tecan for children with N refractory
Url
/Media/UHS-website-2019/Docs/PaediatricOncology/beacon-protocol-v8.0-07mar2023-signed.pdf
1 to 6 of 6